![](/img/cover-not-exists.png)
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer
Jo, J-C, Lee, J-L, Ryu, M-H, Chang, H M, Kim, M, Lee, H J, Kim, H-S, Shin, J-G, Kim, T-W, Kang, Y-KVolume:
106
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2012.143
Date:
May, 2012
File:
PDF, 357 KB
english, 2012